Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia

Critical Care

Volumn 14, Issue 2, 2010, Pages

  Abe, Ryuzo ^a   Oda, Shigeto ^a   Sadahiro, Tomohito ^a   Nakamura, Masataka ^a   Hirayama, Yo ^a   Tateishi, Yoshihisa ^a   Shinozaki, Koichiro ^a   Hirasawa, Hiroyuki ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

ADULT; ARTICLE; BACTEREMIA; BACTERIUM CULTURE; BACTERIUM ISOLATE; BLOOD CULTURE; BLOOD SAMPLING; CHEMILUMINESCENCE ENZYME IMMUNOASSAY; CLINICAL PRACTICE; CONTROLLED STUDY; DIAGNOSTIC KIT; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FUNGEMIA; FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE SEPSIS; GRAM POSITIVE BACTEREMIA; GRAM POSITIVE BACTERIUM; HOSPITAL PATIENT; HUMAN; IMMUNOASSAY; INTENSIVE CARE UNIT; LENGTH OF STAY; LEUKOCYTE COUNT; LEUKOCYTOSIS; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; AGED; BLOOD; GRAM NEGATIVE INFECTION; GRAM POSITIVE INFECTION; HOSPITALIZATION; IMMUNOLOGY; MEDICAL AUDIT; MICROBIOLOGY; MIDDLE AGED; UNIVERSITY HOSPITAL;

AGED; BACTEREMIA; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE UNITS; MALE; MEDICAL AUDIT; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 78149250525     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc8898     Document Type: Article

References (26)

1. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348:1546-1554. 10.1056/NEJMoa022139, 12700374.
2. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003, 348:138-150. 10.1056/NEJMra021333, 12519925.
3. Bearman GM, Wenzel RP. Bacteremias: a leading cause of death. Arch Med Res 2005, 36:646-659. 10.1016/j.arcmed.2005.02.005, 16216646.
4. Renaud B, Brun-Buisson C. Outcomes of primary and catheter-related bacteremia. A cohort and case-control study in critically ill patients. Am J Respir Crit Care Med 2001, 163:1584-1590.
5. Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999, 160:976-981.
6. Annane D, Aegerter P, Jars-Guincestre MC, Guidet B. Current epidemiology of septic shock: the CUB-Rea Network. Am J Respir Crit Care Med 2003, 168:165-172. 10.1164/rccm.2201087, 12851245.
7. Garrouste-Orgeas M, Timsit JF, Tafflet M, Misset B, Zahar JR, Soufir L, Lazard T, Jamali S, Mourvillier B, Cohen Y, De Lassence A, Azoulay E, Cheval C, Descorps-Declere A, Adrie C, Costa de Beauregard MA, Carlet J, . OUTCOMEREA Study Group Excess risk of death from intensive care unit-acquired nosocomial bloodstream infections: a reappraisal. Clin Infect Dis 2006, 42:1118-1126. 10.1086/500318, 16575729, OUTCOMEREA Study Group.
8. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004, 39:309-317. 10.1086/421946, 15306996.
9. Oda S, Hirasawa H, Shiga H, Nakanishi K, Matsuda K, Nakamua M. Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis. Cytokine 2005, 29:169-175. 10.1016/j.cyto.2004.10.010, 15652449.
10. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20:864-874.
11. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829. 10.1097/00003246-198510000-00009, 3928249.
12. Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 1998, 26:1793-1800.
13. Lotze MT, Zeh HJ, Rubartelli A, Sparvero LJ, Amoscato AA, Washburn NR, Devera ME, Liang X, Tor M, Billiar T. The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol Rev 2007, 220:60-81. 10.1111/j.1600-065X.2007.00579.x, 17979840.
14. Fisher CJ, Opal SM, Dhainaut JF, Stephens S, Zimmerman JL, Nightingale P, Harris SJ, Schein RM, Panacek EA, Vincent JL, Foulke GE, Warren EL, Garrard C, Park G, Bodmer MW, Cohen J, der Linden CV, Cross AS, Sadoff JC, . The CB0006 Sepsis Syndrome Study Group Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group. Crit Care Med 1993, 21:318-327. The CB0006 Sepsis Syndrome Study Group.
15. Oppenheim JJ, Yang D. Alarmins: chemotactic activators of immune responses. Curr Opin Immunol 2005, 17:359-365. 10.1016/j.coi.2005.06.002, 15955682.
16. Rubulotta F, Marshall JM, Ramsay G, Nelson D, Levy M, Williams M. Predisposition, insult/infection, response, and organ dysfunction: A new model for staging severe sepsis. Crit Care Med 2009, 37:1329-1335. 10.1097/CCM.0b013e31819d5db1, 19242329.
17. Webb SA, Kahler CM. Bench-to-bedside review: Bacterial virulence and subversion of host defences. Crit Care 2008, 12:234. 10.1186/cc7091, 2646333, 19014410.
18. Gomez MI, Lee A, Reddy B, Muir A, Soong G, Pitt A, Cheung A, Prince A. Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1. Nat Med 2004, 10:842-848. 10.1038/nm1079, 15247912.
19. Jarva H, Jokiranta TS, Wurzner R, Meri S. Complement resistance mechanisms of streptococci. Mol Immunol 2003, 40:95-107. 10.1016/S0161-5890(03)00108-1, 12914816.
20. Finlay BB, McFadden G. Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell 2006, 124:767-782. 10.1016/j.cell.2006.01.034, 16497587.
21. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000, 118:146-155. 10.1378/chest.118.1.146, 10893372.
22. Wu H, Song Z, Hentzer M, Andersen JB, Molin S, Givskov M, Hoiby N. Synthetic furanones inhibit quorum-sensing and enhance bacterial clearance in Pseudomonas aeruginosa lung infection in mice. J Antimicrob Chemother 2004, 53:1054-1061. 10.1093/jac/dkh223, 15117922.
23. Clatworthy AE, Pierson E, Hung DT. Targeting virulence: a new paradigm for antimicrobial therapy. Nat Chem Biol 2007, 3:541-548. 10.1038/nchembio.2007.24, 17710100.
24. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801. 10.1016/j.cell.2006.02.015, 16497588.
25. Elson G, Dunn-Siegrist I, Daubeuf B, Pugin J. Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria. Blood 2007, 109:1574-1583. 10.1182/blood-2006-06-032961, 17038528.
26. Sirio CA, Tajimi K, Tase C, Knaus WA, Wagner DP, Hirasawa H, Sakanishi N, Katsuya H, Taenaka N. An initial comparison of intensive care in Japan and the United States. Crit Care Med 1992, 20:1207-1215. 10.1097/00003246-199209000-00006, 1521435.